BUFS vs SBIO
Comparison between FT VEST LADDERED SMALL CAP MODERATE BUFFER ETF (BUFS, ETF) and ALPS MEDICAL BREAKTHROUGHS ETF (SBIO, ETF).
BUFS vs SBIO - Performance Comparison
Key Characteristics
Financial metrics and valuation ratios
Net Assets
BUFS
$162M
Winner
SBIO
$162M
Expense Ratio
BUFS
1.01%
Winner
SBIO
0.50%
Max Drawdown
Winner
BUFS
15.03%
SBIO
63.06%
Sharpe Ratio
BUFS
1.52
Winner
SBIO
1.79
5Y Beta
Winner
BUFS
0.57
SBIO
1.03
P/E Ratio
BUFS
N/A
SBIO
-12.79
5Y Dividends CAGR
BUFS
N/A
SBIO
9.24%
Debt to Equity
BUFS
N/A
SBIO
2.08%
P/S Ratio
BUFS
N/A
SBIO
6.98
P/B Ratio
BUFS
N/A
SBIO
3.94
BUFS vs SBIO - Holdings Comparison
BUFS and SBIO have 0 common holdings. Overlap is 0.00%
BUFS's top 25 holdings weight is 99.91%. SBIO's top 25 holdings weight is 63.55%.
| Rank | BUFS | SBIO |
|---|---|---|
| #1 | FT VEST US SM CP MOD BUFFR ETF- MAY (SMAY) - 25.09% | ALKERMES PLC (ALKS) - 4.84% |
| #2 | FT VEST U.S. SMALL CAP MOD BUF ETF-FEB (SFEB) - 25.04% | KYMERA THERAPEUTICS INC ORDINARY SHARES (KYMR) - 4.06% |
| #3 | FT VEST U.S. SM CP MOD BUF ETF -NOV (SNOV) - 24.89% | SPYRE THERAPEUTICS INC (SYRE) - 3.93% |
| #4 | FT VEST U.S. SM CP MOD BUF ETF -AUG (SAUG) - 24.89% | MIRUM PHARMACEUTICALS INC (MIRM) - 3.77% |
| #5 | N/A | APOGEE THERAPEUTICS INC (APGE) - 3.21% |
| #6 | N/A | CG ONCOLOGY INC (CGON) - 3.12% |
| #7 | N/A | XENON PHARMACEUTICALS INC (XENE) - 3.02% |
| #8 | N/A | TRAVERE THERAPEUTICS INC ORDINARY SHARES (TVTX) - 2.83% |
| #9 | N/A | CELCUITY INC (CELC) - 2.80% |
| #10 | N/A | EDGEWISE THERAPEUTICS INC (EWTX) - 2.64% |
| #11 | N/A | DIANTHUS THERAPEUTICS INC (DNTH) - 2.57% |
| #12 | N/A | NEWAMSTERDAM PHARMA CO NV (NAMS) - 2.51% |
| #13 | N/A | ACADIA PHARMACEUTICALS INC (ACAD) - 2.48% |
| #14 | N/A | CRINETICS PHARMACEUTICALS INC (CRNX) - 2.35% |
| #15 | N/A | VIKING THERAPEUTICS INC (VKTX) - 2.30% |
| #16 | N/A | DENALI THERAPEUTICS INC (DNLI) - 2.12% |
| #17 | N/A | ORUKA THERAPEUTICS INC (ORKA) - 1.88% |
| #18 | N/A | RELAY THERAPEUTICS INC ORDINARY SHARES (RLAY) - 1.86% |
| #19 | N/A | DISC MEDICINE INC ORDINARY SHARES (IRON) - 1.83% |
| #20 | N/A | STRUCTURE THERAPEUTICS INC ADR (GPCR) - 1.81% |
| #21 | N/A | IDEAYA BIOSCIENCES INC (IDYA) - 1.70% |
| #22 | N/A | n/a (TARS) - 1.70% |
| #23 | N/A | VERA THERAPEUTICS INC CLASS A (VERA) - 1.52% |
| #24 | N/A | MINERALYS THERAPEUTICS INC (MLYS) - 1.35% |
| #25 | N/A | CELLDEX THERAPEUTICS INC (CLDX) - 1.35% |
| Total Holdings | 4 | 87 |
BUFS vs SBIO - Historical Returns
Returns include dividend reinvestment.
1M
Winner
BUFS
+1.83%
SBIO
-4.31%
3M
Winner
BUFS
+8.05%
SBIO
+5.14%
6M
Winner
BUFS
+7.86%
SBIO
+2.95%
1Y
BUFS
+18.71%
Winner
SBIO
+68.66%
5Y(CAGR)
BUFS
N/A
SBIO
+1.91%
10Y(CAGR)
BUFS
N/A
SBIO
+9.09%
Max(CAGR)
Winner
BUFS
+11.19%
SBIO
+7.58%
BUFS vs SBIO - Annual Returns (2014 - 2026)
Returns include dividend reinvestment.
| Year | BUFS | SBIO |
|---|---|---|
| 2026 | +7.90% | +5.18% |
| 2025 | +7.03% | +53.69% |
| 2024 | +6.83% | +4.25% |
| 2023 | N/A | +11.05% |
| 2022 | N/A | -30.19% |
| 2021 | N/A | -17.90% |
| 2020 | N/A | +23.09% |
| 2019 | N/A | +47.58% |
| 2018 | N/A | -13.24% |
| 2017 | N/A | +44.12% |
| 2016 | N/A | -25.20% |
| 2015 | N/A | +26.42% |
| 2014 | N/A | +0.00% |
BUFS vs SBIO Drawdown Comparison
The maximum drawdown for BUFS was -15.03%, occurring on Apr 8, 2025. Recovery took 187 trading sessions.
The maximum drawdown for SBIO was -63.06%, occurring on Oct 27, 2023. This drawdown has not yet recovered.
The current SBIO drawdown is -13.96%.
| Rank | BUFS | SBIO |
|---|---|---|
| #1 | -15.03% Dec 4, 2024 - Sep 5, 2025 | -63.06% Feb 8, 2021 - Oct 27, 2023 |
| #2 | -5.36% Jul 16, 2024 - Aug 26, 2024 | -49.69% Jul 17, 2015 - Jun 6, 2018 |
| #3 | -4.68% Oct 27, 2025 - Dec 10, 2025 | -39.30% Dec 24, 2019 - Jun 23, 2020 |
| #4 | -4.02% Feb 25, 2026 - Apr 9, 2026 | -32.42% Sep 28, 2018 - Nov 25, 2019 |
| #5 | -2.82% Aug 30, 2024 - Sep 19, 2024 | -13.78% Apr 23, 2015 - May 20, 2015 |
| #6 | -1.81% Oct 8, 2025 - Oct 14, 2025 | -13.03% Jun 23, 2020 - Oct 7, 2020 |
| #7 | -1.77% May 31, 2024 - Jul 11, 2024 | -11.31% Mar 19, 2015 - Apr 13, 2015 |
| #8 | -1.68% Nov 11, 2024 - Nov 22, 2024 | -6.72% Jun 6, 2018 - Sep 28, 2018 |
| #9 | -1.48% Oct 16, 2024 - Nov 6, 2024 | -6.30% Jan 27, 2015 - Feb 17, 2015 |
| #10 | -1.44% Jan 22, 2026 - Feb 9, 2026 | -6.29% Jun 22, 2015 - Jul 13, 2015 |
| #11 | -1.34% Dec 11, 2025 - Jan 6, 2026 | -6.19% Dec 22, 2020 - Jan 7, 2021 |
| #12 | -1.34% Sep 19, 2024 - Oct 14, 2024 | -4.88% Oct 13, 2020 - Oct 27, 2020 |
| #13 | -1.33% Jun 4, 2026 - Jun 12, 2026 | -3.81% Jan 14, 2015 - Jan 20, 2015 |
| #14 | -1.27% May 14, 2026 - May 21, 2026 | -3.39% Oct 27, 2020 - Nov 4, 2020 |
| #15 | -1.06% Sep 18, 2025 - Oct 2, 2025 | -3.31% Jan 26, 2021 - Feb 1, 2021 |
Correlation
Correlation between BUFS and SBIO is 0.92 which considered as a very strong positive correlation - the stocks move almost identically together.
0.92
-101
Select Stocks to Compare
Popular: BUFS vs SPYSBIO vs SPY
More Comparisons
Compare with similar stocks